Synbiotic’s CAGR Forecast at 80%, ECS Botanics to Expand Footprint in Germany, & More from Intercure
Synbiotic New research conducted by analysts at NuWays has given German buy-and-build cannabis brand Synbiotic an updated ‘buy’ recommendation.